Literature DB >> 31667786

Circ_ANKIB1 stabilizes the regulation of miR-19b on SOCS3/STAT3 pathway to promote osteosarcoma cell growth and invasion.

Yi-Xin Du1, Lin-Xin Guo1, Han-Song Pan1, Yi-Min Liang1, Xiang Li2.   

Abstract

Osteosarcoma is a highly malignant tumor. The molecular mechanism of its occurrence and development has not yet been clarified. Current studies have found that noncoding RNAs, such as circular RNAs (circRNAs) and microRNAs (miRNAs), play important regulatory roles in the progression of diseases. Our previous studies have shown that miR-19b is an oncogene in osteosarcoma. Further studies have shown that circ_ANKIB1 has binding sites for miR-19b, and both molecules were generally upregulated in osteosarcoma cells. RIP assay, RNA pull down, and dual-luciferase reporter gene assay showed that circ_ANKIB1 could directly bind to miR-19b and act as an miR-19b sponge in osteosarcoma cells. Circ_ANKIB1 promoted miR-19b expression, inhibited the expression of the downstream target gene SOCS3, and then activated the STAT3 pathway. When cotransfected with circ_ANKIB1 siRNA, and miR-19b mimics, the expression of SOCS3 and the phosphorylation level of STAT3 did not change significantly. Continuous detection of cell growth and invasion showed that the downregulation of circ_ANKIB1 or miR-19b significantly inhibited cell proliferation and invasion, but increased the apoptotic level. When cotransfected with circ_ANKIB1 siRNA and miR-19b mimics or SOCS3 siRNA, the cell proliferation, apoptosis, and invasion levels did not change significantly, suggesting that circ_ANKIB1 could affect the STAT3 pathway and osteosarcoma cell growth and invasion by enhancing the regulation of miR-19b on the downstream target gene SOCS3. These findings suggest that circRNAs stabilize miRNA functions, and further studies on this new function of circRNAs will provide a meaningful reference for the diagnosis and treatment of tumors and other diseases.

Entities:  

Keywords:  CircRNA; Osteosarcoma; SOCS3; STAT3; miR-19b

Mesh:

Substances:

Year:  2019        PMID: 31667786     DOI: 10.1007/s13577-019-00298-6

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  25 in total

1.  Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing.

Authors:  Zhu Kun-Peng; Ma Xiao-Long; Zhang Lei; Zhang Chun-Lin; Hu Jian-Ping; Zhan Tai-Cheng
Journal:  Epigenomics       Date:  2018-09-07       Impact factor: 4.778

Review 2.  Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease.

Authors:  Gillian A Durham; Jamie J L Williams; M Talat Nasim; Timothy M Palmer
Journal:  Trends Pharmacol Sci       Date:  2019-04-02       Impact factor: 14.819

3.  Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function.

Authors:  Monika Piwecka; Petar Glažar; Luis R Hernandez-Miranda; Sebastian Memczak; Susanne A Wolf; Agnieszka Rybak-Wolf; Andrei Filipchyk; Filippos Klironomos; Cledi Alicia Cerda Jara; Pascal Fenske; Thorsten Trimbuch; Vera Zywitza; Mireya Plass; Luisa Schreyer; Salah Ayoub; Christine Kocks; Ralf Kühn; Christian Rosenmund; Carmen Birchmeier; Nikolaus Rajewsky
Journal:  Science       Date:  2017-08-10       Impact factor: 47.728

4.  Overexpression of hsa_circ_0007534 predicts unfavorable prognosis for osteosarcoma and regulates cell growth and apoptosis by affecting AKT/GSK-3β signaling pathway.

Authors:  Baoquan Li; Xiaoguang Li
Journal:  Biomed Pharmacother       Date:  2018-08-22       Impact factor: 6.529

5.  Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.

Authors:  Chunlei He; Hui Gao; Xiaona Fan; Maoyuan Wang; Wuyang Liu; Weiming Huang; Yadong Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 6.  CircRNA: functions and properties of a novel potential biomarker for cancer.

Authors:  Shujuan Meng; Hecheng Zhou; Ziyang Feng; Zihao Xu; Ying Tang; Peiyao Li; Minghua Wu
Journal:  Mol Cancer       Date:  2017-05-23       Impact factor: 27.401

7.  Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.

Authors:  Yuanyuan Gu; Shuoxin Liu; Xiaodan Zhang; Guimin Chen; Hongwei Liang; Mengchao Yu; Zhicong Liao; Yong Zhou; Chen-Yu Zhang; Tao Wang; Chen Wang; Junfeng Zhang; Xi Chen
Journal:  Protein Cell       Date:  2017-03-31       Impact factor: 14.870

8.  Circular RNA circ_HIPK3 is down-regulated and suppresses cell proliferation, migration and invasion in osteosarcoma.

Authors:  Ma Xiao-Long; Zhu Kun-Peng; Zhang Chun-Lin
Journal:  J Cancer       Date:  2018-04-26       Impact factor: 4.207

9.  miR-19b-3p promotes colon cancer proliferation and oxaliplatin-based chemoresistance by targeting SMAD4: validation by bioinformatics and experimental analyses.

Authors:  Tao Jiang; Ling Ye; Zhongbo Han; Yuan Liu; Yinxue Yang; Zhihai Peng; Junwei Fan
Journal:  J Exp Clin Cancer Res       Date:  2017-09-22

Review 10.  An emerging function of circRNA-miRNAs-mRNA axis in human diseases.

Authors:  Dawei Rong; Handong Sun; Zhouxiao Li; Shuheng Liu; Chaoxi Dong; Kai Fu; Weiwei Tang; Hongyong Cao
Journal:  Oncotarget       Date:  2017-07-10
View more
  11 in total

1.  MicroRNA-19b Downregulates NR3C1 and Enhances Oxaliplatin Chemoresistance in Colon Cancer via the PI3K/AKT/mTOR Pathway.

Authors:  Zhongbo Han; Chao Zhang; Qingfeng Wang; Liang Li; Meng Wang; Xi Li; Chunxia Yang
Journal:  Clin Med Insights Oncol       Date:  2021-05-05

2.  Circular RNA circTUBGCP3 Is Up-Regulated and Promotes Cell Proliferation, Migration and Survivability via Sponge mir-30b in Osteosarcoma.

Authors:  Yining Xu; Teng Yao; Kangmao Huang; Gang Liu; Yizhen Huang; Jun Gao; Huali Ye; Shuying Shen; Jianjun Ma
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

3.  Circular RNA circANKIB1 promotes the progression of osteosarcoma by regulating miR-217/PAX3 axis.

Authors:  Xi Zhu; Changhao Liu; Jiandang Shi; Zhanwen Zhou; Suoli Chen; Sayed Abdulla Jami
Journal:  J Bone Oncol       Date:  2021-01-14       Impact factor: 4.072

4.  LncRNA CCDC26 Interacts with CELF2 Protein to Enhance Myeloid Leukemia Cell Proliferation and Invasion via the circRNA_ANKIB1/miR-195-5p/PRR11 Axis.

Authors:  Chengliang Li; Jianjun Mu; Yingpeng Shi; Hong Xin
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

5.  Identification of key biomarkers and functional pathways in osteosarcomas with lung metastasis: Evidence from bioinformatics analysis.

Authors:  Denghua Liu; Rui Zhou; Aiguo Zhou
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

6.  Hsa_circ_0008259 modulates miR-21-5p and PDCD4 expression to restrain osteosarcoma progression.

Authors:  Kai Guan; Shizhang Liu; Keke Duan; Xiaoxia Zhang; Huitong Liu; Bingqiang Xu; Xi Wang; Xin Jin
Journal:  Aging (Albany NY)       Date:  2021-12-14       Impact factor: 5.682

7.  CircPTCH1 Promotes Migration in Lung Cancer by Regulating MYCN Expression Through miR-34c-5p.

Authors:  ZhenYu Shen; ShengHua Sun
Journal:  Onco Targets Ther       Date:  2021-09-10       Impact factor: 4.147

8.  circRNA 001306 enhances hepatocellular carcinoma growth by up-regulating CDK16 expression via sponging miR-584-5p.

Authors:  Qian Liu; Cixiao Wang; Zeyou Jiang; Shan Li; Fang Li; Hua-Bing Tan; Su-Yang Yue
Journal:  J Cell Mol Med       Date:  2020-11-01       Impact factor: 5.295

9.  miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.

Authors:  Wei Liu; Qiuping Long; Wei Zhang; Dehui Zeng; Bingbing Hu; Shengyao Liu; Li Chen
Journal:  Aging (Albany NY)       Date:  2021-08-13       Impact factor: 5.682

10.  THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma.

Authors:  Shuai Yang; Bing Wang; Chang Liu; Qizun Wang; Ronghuan Wang; Weiliang Su; Youfu Zhu; Maohua Li; Zhaoyang Guo; Xiaolin Wu; Feng Chen
Journal:  Oxid Med Cell Longev       Date:  2021-10-14       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.